Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Reynolds

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Experimental Cell Research|January 12, 1999
Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosisC P Anderson, J M Tsai, W E Meek, et al.
Human Gene Therapy|March 21, 1998
A Phase I study of human gamma interferon gene-transduced tumor cells in patients with neuroblastomaR C Seeger, J D Rosenblatt, R E Duerst, et al.
Progress in Clinical and Biological Research|January 1, 1988
Characterization of human neuroblastoma cell lines that lack N-myc gene amplificationR K Wada, R C Seeger, G M Brodeur, et al.
Cancer Research|February 24, 2001
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastomaP M Thompson, J M Maris, M D Hogarty, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell linesC P Anderson, J Tsai, W Chan, et al.
Cancer|December 1, 1993
Human neuroblastoma cell lines that express N-myc without gene amplificationR K Wada, R C Seeger, G M Brodeur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantationJ G Villablanca, A A Khan, V I Avramis, et al.
Journal of the National Cancer Institute|March 1, 1986
Characterization of human neuroblastoma cell lines established before and after therapyC P Reynolds, J L Biedler, B A Spengler, et al.
Oncogene|April 1, 1992
Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cellsR K Wada, R C Seeger, C P Reynolds, et al.
Medical and Pediatric Oncology|January 1, 1992
13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study GroupJ Z Finklestein, M D Krailo, C Lenarsky, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Experimental Cell Research|January 12, 1999
Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosisC P Anderson, J M Tsai, W E Meek, et al.
Human Gene Therapy|March 21, 1998
A Phase I study of human gamma interferon gene-transduced tumor cells in patients with neuroblastomaR C Seeger, J D Rosenblatt, R E Duerst, et al.
Progress in Clinical and Biological Research|January 1, 1988
Characterization of human neuroblastoma cell lines that lack N-myc gene amplificationR K Wada, R C Seeger, G M Brodeur, et al.
Cancer Research|February 24, 2001
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastomaP M Thompson, J M Maris, M D Hogarty, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell linesC P Anderson, J Tsai, W Chan, et al.
Cancer|December 1, 1993
Human neuroblastoma cell lines that express N-myc without gene amplificationR K Wada, R C Seeger, G M Brodeur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantationJ G Villablanca, A A Khan, V I Avramis, et al.
Journal of the National Cancer Institute|March 1, 1986
Characterization of human neuroblastoma cell lines established before and after therapyC P Reynolds, J L Biedler, B A Spengler, et al.
Oncogene|April 1, 1992
Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cellsR K Wada, R C Seeger, C P Reynolds, et al.
Medical and Pediatric Oncology|January 1, 1992
13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study GroupJ Z Finklestein, M D Krailo, C Lenarsky, et al.
Pageof 12